$CRSP
CRISPR Therapeutics AG

2019 Q2 Form 10-Q Financial Statement

#000156459019026600 Filed on July 29, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2018 Q2
Revenue $318.0K $1.088M
YoY Change -70.77% -69.63%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $15.80M $12.70M
YoY Change 24.41% 62.82%
% of Gross Profit
Research & Development $39.53M $25.63M
YoY Change 54.23% 49.73%
% of Gross Profit
Depreciation & Amortization $1.000M $900.0K
YoY Change 11.11% 28.57%
% of Gross Profit
Operating Expenses $55.30M $38.37M
YoY Change 44.11% 54.19%
Operating Profit -$54.98M -$37.29M
YoY Change 47.46% 75.0%
Interest Expense -$1.000M -$1.200M
YoY Change -16.67% 140.0%
% of Operating Profit
Other Income/Expense, Net $1.369M $200.0K
YoY Change 584.5% -130.03%
Pretax Income -$53.61M -$38.28M
YoY Change 40.04% 74.24%
Income Tax $100.0K $100.0K
% Of Pretax Income
Net Earnings -$53.70M -$38.38M
YoY Change 39.91% 71.99%
Net Earnings / Revenue -16886.48% -3527.57%
Basic Earnings Per Share -$1.01 -$0.82
Diluted Earnings Per Share -$1.01 -$0.82
COMMON SHARES
Basic Shares Outstanding 53.19M 46.84M
Diluted Shares Outstanding 53.19M 46.84M

Balance Sheet

Concept 2019 Q2 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $427.9M $319.7M
YoY Change 33.84% 17.41%
Cash & Equivalents $427.9M $322.9M
Short-Term Investments
Other Short-Term Assets $10.30M $9.900M
YoY Change 4.04% 350.0%
Inventory
Prepaid Expenses
Receivables $321.0K $900.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $438.5M $330.5M
YoY Change 32.67% 17.5%
LONG-TERM ASSETS
Property, Plant & Equipment $20.16M $18.40M
YoY Change 9.54% -7.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $669.0K $3.900M
YoY Change -82.85% 1545.57%
Total Long-Term Assets $55.77M $22.60M
YoY Change 146.78% -4.6%
TOTAL ASSETS
Total Short-Term Assets $438.5M $330.5M
Total Long-Term Assets $55.77M $22.60M
Total Assets $494.2M $353.1M
YoY Change 39.97% 15.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.143M $4.500M
YoY Change 58.73% 75.85%
Accrued Expenses $18.63M $12.70M
YoY Change 46.68% 6.83%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $31.41M $18.50M
YoY Change 69.79% 16.98%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $220.0K $69.50M
YoY Change -99.68% 35001.01%
Total Long-Term Liabilities $220.0K $69.50M
YoY Change -99.68% 35001.01%
TOTAL LIABILITIES
Total Short-Term Liabilities $31.41M $18.50M
Total Long-Term Liabilities $220.0K $69.50M
Total Liabilities $126.6M $88.00M
YoY Change 43.82% -17.89%
SHAREHOLDERS EQUITY
Retained Earnings -$393.7M
YoY Change
Common Stock $761.4M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $57.00K
YoY Change
Treasury Stock Shares $257.0K
Shareholders Equity $367.7M $265.2M
YoY Change
Total Liabilities & Shareholders Equity $494.2M $353.1M
YoY Change 39.97% 15.78%

Cashflow Statement

Concept 2019 Q2 2018 Q2
OPERATING ACTIVITIES
Net Income -$53.70M -$38.38M
YoY Change 39.91% 71.99%
Depreciation, Depletion And Amortization $1.000M $900.0K
YoY Change 11.11% 28.57%
Cash From Operating Activities -$36.38M -$25.21M
YoY Change 44.31% 57.86%
INVESTING ACTIVITIES
Capital Expenditures -$2.170M -$520.0K
YoY Change 317.31% -60.9%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.170M -$520.0K
YoY Change 317.31% -60.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 29.65M 3.730M
YoY Change 694.91% 432.86%
NET CHANGE
Cash From Operating Activities -36.38M -25.21M
Cash From Investing Activities -2.170M -520.0K
Cash From Financing Activities 29.65M 3.730M
Net Change In Cash -8.900M -22.00M
YoY Change -59.55% 32.53%
FREE CASH FLOW
Cash From Operating Activities -$36.38M -$25.21M
Capital Expenditures -$2.170M -$520.0K
Free Cash Flow -$34.21M -$24.69M
YoY Change 38.56% 68.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15768000
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25633000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
73355000
CY2019Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y3M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y3M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y6M
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y3M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
256989
CY2018Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
307936
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-9000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
30697000
us-gaap Operating Expenses
OperatingExpenses
104052000
us-gaap Operating Income Loss
OperatingIncomeLoss
-103406000
CY2019Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1012000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
85000
CY2018Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
14000
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.03
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.03
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
55445241
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
52183139
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53756046
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52160798
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53499057
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51852862
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39533000
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12741000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
55301000
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
38374000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-54983000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-37286000
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-38401000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-102109000
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
1963000
CY2018Q2 crsp Research And Development Expense From Related Party
ResearchAndDevelopmentExpenseFromRelatedParty
1246000
crsp Research And Development Expense From Related Party
ResearchAndDevelopmentExpenseFromRelatedParty
14459000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
187832000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-53699000
crsp Security12b Title
Security12bTitle
Common Shares, CHF 0.03 par value
crsp Security Exchange Name
SecurityExchangeName
NASDAQ Stock Market LLC
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
427885000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
456649000
CY2019Q2 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
321000
CY2018Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
88000
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
321000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
88000
CY2019Q2 crsp Prepaid Expense And Other Assets Related Parties Current
PrepaidExpenseAndOtherAssetsRelatedPartiesCurrent
3318000
CY2018Q4 crsp Prepaid Expense And Other Assets Related Parties Current
PrepaidExpenseAndOtherAssetsRelatedPartiesCurrent
3417000
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10267000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9658000
CY2019Q2 us-gaap Assets Current
AssetsCurrent
438473000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
466395000
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20156000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18500000
CY2019Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
262000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
289000
CY2019Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3915000
CY2018Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3163000
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
30770000
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
669000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
669000
CY2019Q2 us-gaap Assets
Assets
494245000
CY2018Q4 us-gaap Assets
Assets
489016000
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
7143000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5069000
CY2019Q2 crsp Accrued Expenses Related Parties Current
AccruedExpensesRelatedPartiesCurrent
3312000
CY2018Q4 crsp Accrued Expenses Related Parties Current
AccruedExpensesRelatedPartiesCurrent
1700000
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
18628000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20852000
CY2019Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
542000
CY2018Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
402000
CY2018Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
1202000
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4880000
CY2019Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
219000
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
221000
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
31412000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
27746000
CY2019Q2 crsp Contract With Customer Liability Noncurrent With Related Parties
ContractWithCustomerLiabilityNoncurrentWithRelatedParties
57730000
CY2018Q4 crsp Contract With Customer Liability Noncurrent With Related Parties
ContractWithCustomerLiabilityNoncurrentWithRelatedParties
57780000
CY2019Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
57730000
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
57780000
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
11052000
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
37200000
CY2019Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
220000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
243000
CY2019Q2 us-gaap Liabilities
Liabilities
126562000
CY2018Q4 us-gaap Liabilities
Liabilities
96821000
CY2019Q2 crsp Common Stock Conditional Capital
CommonStockConditionalCapital
23948128
CY2018Q4 crsp Common Stock Conditional Capital
CommonStockConditionalCapital
20498996
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
1630000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
1584000
CY2019Q2 us-gaap Treasury Stock Value
TreasuryStockValue
57000
CY2018Q4 us-gaap Treasury Stock Value
TreasuryStockValue
57000
CY2019Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
759796000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
682245000
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-393676000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-291569000
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-10000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
367683000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
392195000
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
494245000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
489016000
CY2019Q2 us-gaap Revenues
Revenues
318000
CY2018Q2 us-gaap Revenues
Revenues
1088000
us-gaap Revenues
Revenues
646000
us-gaap Revenues
Revenues
2446000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
45152000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21577000
us-gaap Operating Expenses
OperatingExpenses
66729000
CY2018Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1153000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
29000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1469000
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38284000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-66689000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-38380000
us-gaap Net Income Loss
NetIncomeLoss
-102107000
us-gaap Net Income Loss
NetIncomeLoss
-66680000
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.01
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.82
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.94
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.44
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
53188041
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
46842316
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
52643649
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
46362538
CY2019Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
318000
CY2018Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
881000
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
646000
CY2019Q2 crsp Research And Development Expense From Related Party
ResearchAndDevelopmentExpenseFromRelatedParty
6870000
crsp Research And Development Expense From Related Party
ResearchAndDevelopmentExpenseFromRelatedParty
2352000
CY2018Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
122597000
CY2018Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
13000
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2656000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6673000
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
12000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-28300000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
290335000
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3729000
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9477000
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-21000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-38380000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
265154000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
392195000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
379810000
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
28114000
CY2019Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
16000
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1254000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12198000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-10000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-53699000
us-gaap Profit Loss
ProfitLoss
-102107000
us-gaap Profit Loss
ProfitLoss
-66680000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2010000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1691000
us-gaap Share Based Compensation
ShareBasedCompensation
20857000
us-gaap Share Based Compensation
ShareBasedCompensation
13906000
crsp Income Loss From Equity Method Investments And Investment Compensation Expense
IncomeLossFromEquityMethodInvestmentsAndInvestmentCompensationExpense
-2037000
crsp Income Loss From Equity Method Investments And Investment Compensation Expense
IncomeLossFromEquityMethodInvestmentsAndInvestmentCompensationExpense
-2244000
us-gaap Other Noncash Income
OtherNoncashIncome
169000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
233000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1682000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1399000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3804000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-849000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3764000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-50000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-244000
crsp Increase Decrease In Deferred Rent Payable
IncreaseDecreaseInDeferredRentPayable
-381000
crsp Increase Decrease In Operating Lease Assets And Liabilities
IncreaseDecreaseInOperatingLeaseAssetsAndLiabilities
-391000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
6000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
88000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-80119000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-47903000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3271000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1078000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
52294000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6433000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3086000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
50000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-2000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
55380000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
128980000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-9000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-28012000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
79990000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
242912000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
431800000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
322902000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
702000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
125000
crsp Equity Issuance Costs In Accounts Payable And Accrued Expenses
EquityIssuanceCostsInAccountsPayableAndAccruedExpenses
477000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Significant estimates in these consolidated financial statements have been made in connection with the calculation of revenues, research and development expenses and equity-based compensation expense. <span style="color:#000000;">The Company bases its estimates on historical experience and various other assumptions, including, in certain circumstances, future projections that management believes to be reasonable. Actual results could differ from those estimates. Changes in estimates are reflected in reported results in the period in which they become known.</span></p>
CY2018Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
1202000
CY2018 us-gaap Sublease Income
SubleaseIncome
176000
CY2019Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
29514000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25875000
CY2019Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9358000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7375000
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20156000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18500000
CY2019Q2 us-gaap Depreciation
Depreciation
1000000.0
us-gaap Depreciation
Depreciation
2000000.0
CY2018Q2 us-gaap Depreciation
Depreciation
900000
us-gaap Depreciation
Depreciation
1700000
CY2019Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5604000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7321000
CY2019Q2 crsp Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
9266000
CY2018Q4 crsp Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
7973000
CY2018Q4 crsp Accrued License Fees Current
AccruedLicenseFeesCurrent
625000
CY2019Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2096000
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1848000
CY2019Q2 crsp Accrued Intellectual Property Costs Current
AccruedIntellectualPropertyCostsCurrent
1164000
CY2018Q4 crsp Accrued Intellectual Property Costs Current
AccruedIntellectualPropertyCostsCurrent
2193000
CY2019Q2 crsp Accrued Property And Equipment
AccruedPropertyAndEquipment
387000
CY2018Q4 crsp Accrued Property And Equipment
AccruedPropertyAndEquipment
294000
CY2019Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
111000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
598000
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
18628000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20852000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
7362000
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
30770000
CY2019Q2 crsp Lease Assets
LeaseAssets
30770000
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4880000
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
37200000
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
42080000
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1904000
us-gaap Operating Lease Cost
OperatingLeaseCost
3726000
CY2019Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1123000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
2261000
CY2019Q2 us-gaap Variable Lease Cost
VariableLeaseCost
683000
us-gaap Variable Lease Cost
VariableLeaseCost
1413000
us-gaap Sublease Income
SubleaseIncome
525000
CY2019Q2 us-gaap Lease Cost
LeaseCost
3710000
us-gaap Lease Cost
LeaseCost
6875000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
4419000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
8566000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
8507000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
7345000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
23254000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
59453000
CY2019Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
17373000
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
42080000
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.098
crsp Operating Lease Cash Payments Included In Measurement Of Lease Liabilities
OperatingLeaseCashPaymentsIncludedInMeasurementOfLeaseLiabilities
3940000
us-gaap Operating Lease Payments
OperatingLeasePayments
3940000
crsp Joint Venture Agreement Date
JointVentureAgreementDate
2015-12-19
CY2016Q4 us-gaap Equity Method Investments
EquityMethodInvestments
36500000
CY2016 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-36500000
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
55445241
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.03
CY2019Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
256989
CY2019Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1683609
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12198000
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9477000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
22894000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16150000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6689311
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
25.42
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
68572000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1948773
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
36.05
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
263700
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
12.23
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
178518
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
33.48
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8195866
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
28.19
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
167076000
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3198255
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
19.51
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
91777000
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
8195866
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
28.19
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
167076000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.693
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.722
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.025
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.027
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2019Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
104300000
CY2018Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.003
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.003
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8533869
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6787111
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
100000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000
CY2019Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.002
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.002
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
100000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000

Files In Submission

Name View Source Status
0001564590-19-026600-index-headers.html Edgar Link pending
0001564590-19-026600-index.html Edgar Link pending
0001564590-19-026600.txt Edgar Link pending
0001564590-19-026600-xbrl.zip Edgar Link pending
crsp-10q_20190630.htm Edgar Link pending
crsp-10q_20190630_htm.xml Edgar Link completed
crsp-20190630.xsd Edgar Link pending
crsp-20190630_cal.xml Edgar Link unprocessable
crsp-20190630_def.xml Edgar Link unprocessable
crsp-20190630_lab.xml Edgar Link unprocessable
crsp-20190630_pre.xml Edgar Link unprocessable
crsp-ex101_284.htm Edgar Link pending
crsp-ex102_285.htm Edgar Link pending
crsp-ex311_8.htm Edgar Link pending
crsp-ex312_7.htm Edgar Link pending
crsp-ex321_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending